Contact Force Catheter Research Articles

Long-term prognosis in patients undergoing atrial fibrillation ablation

Abstract Aims The aim of the analysis was to assess the risk of atrial fibrillation (AF) recurrence in the long-term observation of contemporary patients undergoing pulmonary vein isolation (PVI), who did not have recurrence during the first year after catheter ablation. Methods Retrospective analysis has been performed. Inclusion criteria: (1) the patients undergoing their first PVI in years 2017–2022, (2) the electroanatomical system, contact force catheters and lesion indexes (Ablation Index or Lesion Size Index) were used, (3) no recurrences were observed during the first 12 months of follow-up, and (4) follow-up longer than 12 months was available. Demographic, clinical and echocardiographic data were collected. Follow-up was based on ambulatory visits with ECG/holter monitoring or implanted device interrogation, when available. Results A total of 247 patients were included. The median follow-up was 22 months (interquartile range, 16–31 months). After 24 months, ablation efficacy was 84%, and after 36 months, it was 72%. In the univariate Cox regression analysis, age, previous electrical cardioversion, glomerular filtration rate (eGFR) and the presence of coronary artery disease were linked to AF-free survival. Interestingly, nonparoxysmal AF, left atrial (LA) dimension, heart failure, hypertension or diabetes were not linked to the risk of long-term recurrences. In multivariate Cox regression analysis, presence of coronary artery disease and previous electrical cardioversion were independently linked to the risk of long-term recurrence. In 127 (51.4%) patients, information about the presence of low voltage areas (LVA) was available, and in 21 (16.5%) patients in this group, the presence of LVA was found. Survival of patients with LVA was strikingly worse than that of those without (Figure 1), log-rank test p <0.0001. Conclusions Patients who had no recurrences within one year after PVI, still have substantial risk of recurrence in the next 2 years. That concerns specially the patients who had LVA in the electroanatomical mapping.

Posterior wall isolation in patients with persistent atrial fibrillation: a single center comparative study between ablation index and very high power short duration radiofrequency ablation protocol

Abstract Background Circumferential pulmonary veins ablation (CPVA) with posterior wall isolation (PWI) using radiofrequency catheter ablation (RFCA) is gaining increasing interest in terms of safety and efficacy. Purpose To compare procedural data and efficacy between two radiofrequency ablation protocols for the treatment of persistent atrial fibrillation (PersAF): very high power-short duration (vHPSD) ablation using a novel temperature-controlled ablation catheter and Ablation Index (AI) guided RFCA using traditional contact-force catheter. Methods This single center prospective study enrolled 75 consecutive patients (Group 1) with symptomatic PersAF undergoing RFCA using a novel contact-force catheter optimized for temperature-controlled ablation with microelectrodes and 6 thermocouples for real-time temperature monitoring during ablation. The vHPSD algorithm modulates power to maintain target temperature during these lesions (90 Watts, 4 s) in the posterior wall. RF delivery in anterior regions was performed in a temperature guided setting (1-45W, 45°C) to achieve a 500-550 AI. These patients were compared to 75 propensity matched patients (Group 2) undergoing PersAF ablation with traditional AI-guided ablation. Procedural data were compared between the two groups (Table 1). Procedural outcome was considered as loop recorder documented atrial arrhythmias recurrences and compared between the two groups. Results Seventy-five patients (69% male, 63.1±11.2 years old) underwent ablation with vHPSD protocol (Group 1). CPVA and PWI was achieved in all patients with total procedure and fluoroscopy times of 67.5±28.8 min and 4.5±2.8 min, respectively. After 12-month median follow-up, 57/75 patients (76%) were free from AF. Seventy-five propensity matched patients (69% male, 60.7±9.9 years old) have undergone ablation with standard contact-force catheter. CPVA and PWI was achieved in all patients with total procedure and fluoroscopy times of 81.99±20.5 min and 5.7±2.1 min, respectively. After 12-month median follow-up, 55/75 patients (73%) were free from AF. Procedural and fluoroscopy times were significantly lower in in Group 1 than in Group 2 (Table 1). AF recurrencies were comparable between the two groups as assessed with survival analysis (Figure 1, log-rank 0.509). There were no deaths or other severe periprocedural complications. Conclusions PWI on top of CPVA is effective in limiting arrhythmic recurrences following RFCA of PersAF. Compared to standard AI guided ablation, vHPSD protocol significantly reduces procedural time and fluoroscopy exposure. Clinical outcomes between the two protocols are similar.Figure 1

A role for Local Impedance in CF guided PVI: initial results from the LOCALIZE CF Trial

Abstract Background Contact force catheters (CF) in combination with high-resolution 3D mapping are the gold standard for treatment of complex arrhythmias. Stable CF and catheter position increase both the safety and effectiveness of energy delivery. To date, local impedance (LI) is the only established parameter for real-time measure of lesion quality. Other methods tend to use surrogate parameters. Catheter ablation may be further improved by combining CF and LI. Purpose LOCALIZE CF assessed the utility of LI in addition to CF in predicting lesion durability during RF PVI procedures for paroxysmal atrial fibrillation (PAF). Methods LOCALIZE CF is an international, multicenter non-randomized trial consisting of an index PVI and invasive redo mapping procedure at 3 months. Patients (pts) with PAF underwent de novo PVI using a combined CF/LI catheter and 3D mapping system. Operators could use CF but were blinded to LI. Power settings and ablation duration were at operator discretion. PVI was performed with point-by-point circumferential ablation. The procedural endpoint was confirmation of entry block for all pulmonary veins (PV) after a 20-minute wait. Secondary endpoints included: safety events, procedural characteristics, and the correlation between LI-values and gaps. Gaps at 3-month remap were analysed by anatomical segment (8/ipsilateral PVI circle, 16/pt). Results This study enrolled 60 pts across 4 European centers, 54 pts completed 3-month remap. On average, pts (25% female) were 61 years of age, BMI 27kg/m2, LVEF 64%, LA diameter 38mm, and CHA2DS2-VASc score 1. High-power (40-45W) short duration was used by 3 of 4 sites (32 patients), with standard power (<40W) in the remainder. First pass isolation, assessed after 20min wait, was achieved in 73% of pts. Acute isolation of all PVs was achieved in all pts. At the 3-month re-map procedure, 92 of 845 segments were found to be reconnected. 3,980 point-to-point index ablations were analysed with respect to gap vs blocked segments. The median CF in gap segments was 11g compared to 13.9g in blocked segments (p<0.0001). Gap segments had significantly lower median LI drop (13Ω) than blocked segments (19Ω; p<0.001). In multivariate analysis, lesion spacing, CF and LI drop all independently predicted block. In ROC curve analysis (>9.5g CF, >20Ω LI), a model including all 3 factors had a significantly greater area under the curve than spacing and CF alone (p<0.0001). Conclusions Real-time measurements such as LI and CF are important for improving the quality and durability of ablations. While CF represents the stability of the catheter, LI reflects real-time lesion formation. The combination of both is important and may improve ablation and avoid gaps. This study suggests that CF >9.5g and LI drop >20Ω are predictors of durable lesion. Thus, LI, when used alongside CF, potentially offers a distinctive measure of ablation effectiveness, complementing the data provided by CF.

Radiofrequency lesion in atrial wall: how variable is it? 9 Tesla MRI analysis of RF lesion volume in a swine model

Abstract Background Little is known about radiofrequency (RF) lesion volume (rLV). Most of animal or ex-vivo studies quantify the size of RF lesions size using width and/or depth, while electrophysiologists use manufacturers’ indirect indices (such as Ablation Index or Lesion Size Index). Purpose We aimed to evaluate rLV by high resolution 9-Tesla magnetic resonance imaging (MRI), in ex-vivo swine model. We studied the variability of rLV and extra-cardiac effects in two groups of swine, one treated with low energy (LE)-long application RF (20W-50 sec) and another treated with high energy (HE)-short application RF (50 W-20 sec). Methods This was a prospective observational study on 18 piglets, that were anesthetized, mechanically ventilated, and divided into LE (n = 9) and HE (n = 9) groups (Figure 1). An irrigated contact force catheter was used to perform RF applications in 4 largely separated spots: 2 on right atrium and 2 on left atrium wall. RF parameters were monitored during RF. Each animal was sacrificed after 5-7 days, and RF lesion samples were excised and acquired by 9 MRI. Results 70 RF applications were performed (36 in LE group and 34 in HE group). MRI was performed on 26 samples of LE group and 28 of HE group (Figure 2). The median RF lesion volume was 89.3 mm3 (IQR 47.9-175.9). Regarding lesion volume, the HE groups showed 35% higher volume than LE group (mean lesion volume 86.2 mm3 vs 116.3 mm3, p = 0.119). HE group also showed more complications (0 vs 7, p=0.02) and more extracardiac lesion (14 vs 18, p=0.613). Conclusions There was a wide and unpredictable variability of RF lesion on atrial wall, even under controlled experimental conditions, which could explain arrhythmias recurrences. The variability seems greatest, although not statistically significant, during HE applications. The dose/effect relationship needs to be carefully studied for treatments of cardiac arrhythmias for both RF and other forms of energy available today.Study flow-chartComparison between groups

Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results.

Contact force (CF)-sensing radiofrequency (RF) catheters with an ablation index have shown reproducible outcomes for the treatment of atrial fibrillation (AF) in large multicentre studies. A dual-energy (DE) focal CF catheter to deliver RF and unipolar/biphasic pulsed field ablation (PFA), integrated with a three-dimensional (3D) mapping system, can provide operators with additional flexibility. The SmartfIRE study assessed the safety and efficacy of this novel technology for the treatment of drug-refractory, symptomatic paroxysmal AF. Results at 3 months post-ablation are presented here. Pulmonary vein isolation (PVI) was performed using a DE focal, irrigated CF-sensing catheter with the recommendation of PFA at posterior/inferior and RF ablation at the anterior/ridge/carina segments. Irrespective of energy, a tag size of 3 mm; an inter-tag distance ≤6 mm; a target index of 550 for anterior, roof, ridge, and carina; and a target index of 400 for posterior and inferior were recommended. Cavotricuspid isthmus ablation was permitted in patients with documented typical atrial flutter. The primary effectiveness endpoint was acute procedural success. The primary safety endpoint was the rate of primary adverse events (PAEs) within 7 days of the procedure. A prespecified patient subset underwent oesophageal endoscopy (EE; 72 h post-procedure), neurological assessment (NA; pre-procedure and discharge), and cardiac computed tomography (CT)/magnetic resonance angiogram (MRA) imaging (pre-procedure and 3 months post-procedure) for additional safety evaluation, and a mandatory remapping procedure (Day 75 ± 15) for PVI durability assessment. Of 149 patients enrolled between February and June 2023, 140 had the study catheter inserted (safety analysis set) and 137 had ablation energy delivered (per-protocol analysis set). The median (Q1/Q3) total procedure and fluoroscopy times were 108.0 (91.0/126.0) and 4.2 (2.3/7.7) min (n = 137). The acute procedural success rate was 100%. First-pass isolation was achieved in 89.1% of patients and 96.8% of veins. Cavotricuspid isthmus ablations were successfully performed in 12 patients [pulsed field (PF) only: 6, RF only: 5, and RF/PF: 1]. The PAE rate was 4.4% [6/137 patients; 2 pulmonary vein (PV) stenoses, 2 cardiac tamponades/perforations, 1 stroke, and 1 pericarditis]. No coronary artery spasm was reported. No oesophageal lesion was seen in the EE subset (0/31, 0%). In the NA subset (n = 30), microemboli lesions were identified in 2 patients (2/30, 6.7%), both of which were resolved at follow-up; only 1 was symptomatic (silent cerebral lesion, 3.3%). In the CT/MRA subset (n = 30), severe PV narrowing (of >70%) was detected in 2 patients (2/30, 6.7%; vein level 2/128, 1.6%), of whom 1 underwent dilatation and stenting and 1 was asymptomatic; both were associated with high index values and a small inter-tag distance. In the PV durability subset (n = 30), 100/115 treated PVs (87%) were durably isolated and 18/30 patients (60.0%) had all PVs durably isolated. A DE focal CF catheter with 3D mapping integration showed a 100% acute success rate with an acceptable safety profile in the treatment of paroxysmal AF. Prespecified 3-month remapping showed notable PVI durability. ClinicalTrials.gov Identifier: NCT05752487.

Combining conventional technique with fluoroscopy integration module in accessory pathway ablation.

Accessory pathway (AP) ablation is a straightforward approach with high success rates, but the fluoroscopy time (FT) is significantly longer in conventional technique. Electroanatomical mapping systems (EMS), reduce the FT, but anatomical and activation mapping may prolong the procedure time (PT). The fluoroscopy integration module (FIM) uses prerecorded fluoroscopy images and allows ablation similar to conventional technique without creating an anatomical map. In this study, we investigated the effects of combining the FIM with traditional technique on PT, success, and radiation exposure. A total of 131 patients who had undergone AP ablation were included in our study. In 37 patients, right and left anterior oblique (RAO-LAO) images were acquired after catheter placement and integrated with the FIM. The ablation procedure was then similar to the conventional technique, but without the use of fluoroscopy. For the purpose of acceleration, anatomical and activation maps have not been created. Contact-force catheters were not used. 94 patients underwent conventional ablation using fluoroscopy only. FIM into AP ablation procedures led to a significant reduction in radiation exposure, lowering FT from 7.4 to 2.8 min (p < .001) and dose-area product from 12.47 to 5.8 μGym² (p < .001). While the FIM group experienced a reasonable longer PT (69 vs. 50 min p < .001). FIM reduces FT regardless of operator experience and location of APs CONCLUSION: Combining FIM integration with conventional AP ablation offers reduced radiation exposure without compromising success rates and complication.

Utilization of 3D mapping systems in interventional electrophysiology and its impact on procedure time and fluoroscopy-Insights from the "Go for Zero Fluoroscopy" project.

The implementation of 3D mapping systems plays an important role in interventional electrophysiology (EP) in recent years. The aim of the present study was to evaluate use of 3D mapping systems regarding fluoroscopy and procedure duration. In the "Go for Zero Fluoroscopy" project 25 European centers provided data of consecutive EP procedures. Data on use of 3D mapping systems as well as utilization of contact force catheters and multipolar mapping catheters were associated with fluoroscopy time, dose area product (DAP), and procedure duration. A 3D mapping system was used in 966 (54%) cases. Use of 3D mapping for atrioventricular nodal reentry tachycardia (AVNRT) was associated with reduced fluoroscopy time (p<0.001), DAP (p=0.04) but increased procedure time (p=0.029). Moreover, fluoroscopy time (p<0.001) and DAP (p=0.005) were significantly lower in the 3D mapping group in ablation of typical atrial flutter. However, the procedure time (p<0.001) increased. Use of 3D mapping in the ablation of accessory pathway (AP) was associated with reduced fluoroscopy time (p<0.001) and DAP (p<0.001) with no significant increase in procedure time (p=0.066). In the case of atrial fibrillation, a 3D mapping system was used in 485 patients (75.8%). Additional use of a contact force catheter was associated with lower fluoroscopy time (p<0.001) and DAP (p<0.001). Use of a multipolar mapping catheter was associated with lower fluoroscopy time (p=0.002). The implementation of 3D mapping systems in the ablation of ventricular tachycardias resulted in a significant increase in the procedure time (p=0.001) without significant differences regarding the DAP (p=0.773) and fluoroscopy time (p=0.249). Use of 3D mapping systems in ablation of supraventricular tachycardias is associated with lower radiation exposure. Nevertheless, the procedure time often increases, except in the case of ablation for AP. Use of contact force catheters and multipolar mapping catheters is associated with yet lower radiation exposure values. Prospective randomized studies are needed to further elucidate potential benefit of these technological tools.

Value of Left Atrial Strain in Predicting Recurrence after Atrial Fibrillation Ablation.

This study tested the relationship between left atrial (LA) function parameters and the results of pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). Consecutive patients undergoing PVI for the first time between 2019 and 2021 were included. Patients underwent radiofrequency ablation using contact force catheters and an electroanatomical system. Follow-up consisted of ambulatory visits/televisits and 7-day Holter monitoring (at 6 and 12 months after ablation). On the day of ablation, all patients underwent transesophageal and transthoracic echocardiography with LA strain analysis. The primary endpoint was atrial tachyarrhythmia recurrence during the follow-up period. Of 221 patients, 22 did not meet the echocardiographic quality criteria, leaving 199 patients. The median follow-up period was 12 months, and 12 patients were lost to follow-up. Recurrences were observed in 67 patients (35.8%) after a mean of 1.06 procedures per patient. The patients were divided into a sinus rhythm (SR, n = 109) group and an AF (n = 90) group based on their cardiac rhythm at the time of echocardiography. In the SR group, univariable analysis showed that LA reservoir strain, LA appendage emptying velocity (LAAV), and LA volume index predicted AF recurrence, with only LAAV being significant in the multivariable analysis. In AF patients, univariable analysis revealed no LA strain parameters predicting AF recurrence.

Fluoroscopy integration module reduces radiation exposure without affecting procedure time in accessory pathway ablation

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Conventional Accessory Pathway (AP) ablation is a straightforward approach with high success rates, but the fluoroscopy time is significantly higher. Electroanatomical mapping systems (EMS), reduce the fluoroscopy time, but anatomical reconstruction and activation mapping prolong the procedure time. The Fluoroscopy Integration Module (FIM) uses prerecorded fluoroscopy images and allows ablation similar to conventional technique without creating an anatomical map. In this study, we investigated the effects of combining the FIM with the traditional technique on procedure time, success, and radiation exposure. Methods 112 patients who underwent AP ablation were included in our study. In 18 patients, right and left anterior oblique (RAO -LAO) images were recorded after the insertion of the catheters and integrated with FIM. Afterwards, ablation was performed similarly to the conventional technique but without using fluoroscopy. To accelerate the procedure anatomical and activation maps were not created. Contact-force catheters were not used. 94 patients were ablated conventionally using only fluoroscopy. Results Combining the FIM with the conventional method significantly reduced radiation exposure (Fluoroscopy time: 3,3±2,6 vs 11,5±11,6 sec, p: 0,001; Dose-area-product (DAP): 7,3±6,2 vs. 28,6±40,5 μGym2, p: 0,003) without affecting the total procedure time ( 64,4±15 vs. 62,6±28,7 sec, p: 0,272 ), time to successful ablation ( 33,2±13,9 vs. 29,7±29,5 sec p: 0,056) and radiofrequency application time ( 183,7±94,4 vs. 167,3±89,8 sec p: 0,336). Conclusion These findings suggest that FIM can be used for rapid and successful ablation of APs with reduced radiation exposure times.

Zero and near zero fluoroscopy catheter ablation of premature ventricular contractions: a multicentre experience

Abstract Funding Acknowledgements Type of funding sources: None. Background Catheter ablation has become an established treatment option for premature ventricular complexes (PVCs). It is well known that the use of fluoroscopy exposes patients and medical staff to potentially harmful stochastic and deterministic effects of ionising radiations. Purpose We sought to analyse procedural outcomes in terms of safety and efficacy using a "zero" or "near zero" X rays approach for treatment of PVCs. Methods The present retrospective, multicentre, observational study included 131 patients having undergone catheter ablation of PVCs using zero or "near zero" (less than 2 minutes) fluoroscopy between 2016 and 2020. Baseline characteristics of the population, acute success and complications derived from the procedure were evaluated, as well as recurrence rate during follow-up. Results Median age was 51.0 years old [38-63], males were 77 (58.8%). Most often cause of ablation were palpitations (90.0%), followed by reduced left ventricular ejection fraction (4.6%) and pre-syncope (14.5%). Among the study population, 26 (19.8%) had a cardiopathy. The median PVC burden before ablation was 15.1% [6%-22.4%]. The most frequent PVC origin was right ventricular outflow tract (n=72; 55.0%) followed by the left ventricle (n=21; 16.0%), LVOT and cusps (n=18; 13.7%) ,aortomitral continuity (n=7; 5.3%). A 3D electro-anatomical mapping system was used in all cases as well as a contact force catheter for mapping and ablation. The mean maximum radiofrequency power applied was 32.9 ± 4.1 W (370 s median time). Median number of applications was 4.5 and mean total procedural time was 117.3 ± 47.5 minutes. Median best prematurity was 31.5 ms. We used isoprenaline in order to induce PVCs in 42% of cases and suppression of PVC was achieved in 127 patients (96.9%). There was only 2 complication (femoral hematoma and arteriovenous fistula conservatively treated). At 12 months, a complete success was documented in 109 patients (83.2%), a reduction in PVC burden was achieved in other 18 patients (13.7%) and a failure was recorded in 4 patients (3.1%). Conclusion The PVC ablation with "zero" or "near-zero" fluoroscopy is a safe procedure with no major complications and good rates of success and recurrence in our multicentre experience.

Electroanatomical voltage mapping with a force-sensing technology catheter for diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Invasive three-dimensional electroanatomical mapping (EAM) can be helpful to diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC). Contact force sensing catheters (CFSC) represent the gold standard to verify adequate tissue contact during EAM. However, normal reference values for right ventricular (RV) EAM as well as substrate characterization in patients with ARVC using CFSC have not been systematically investigated, which was the aim of this prospective study. Methods EAM of the RV during sinus rhythm was performed with the Thermocool SmartTouch catheter via a long sheath in the CARTO3 system in 11 patients with definite ARVC and 5 age- and gender-matched control subjects without structural heart disease. Only points with a mean contact force of ≥4G were analyzed. To account for differences due to RV anatomy, it was divided into 5 segments: RV outflow tract (RVOT), septum, free wall, sub-tricuspid region and apex. Endocardial bipolar and unipolar voltages, signal characteristics and signal duration were analyzed. The impact of catheter orientation on endocardial signals was also assessed. Results A median of 227 (IQR:120-364) endocardial RV points were analyzed. Median bipolar voltage in healthy controls was 3.8mV (range 3.6-4.6, IQR 2.7-5.4), with lower values in the RVOT and higher values in the RV septum. ARVC patients showed significantly lower bipolar voltages as compared to controls (repeated measures ANOVA; between-subjects effect: F=6.443,p=0.024), showing significantly lower bipolar voltage values in the sub-tricuspid region (1.8±1.9vs.4.6±2.9mV,p=0.031) and in the RV apex (2.9±1.4vs.7.2±5.2mV,p=0.024), Figure 1c. Bipolar voltage values in all RV regions yielded a high sensitivity and specificity for ARVC diagnosis (AUC62-78%,p&amp;lt;0.001 for all), with the highest performance for the sub-tricuspid region (AUC78%,95%CI0.75-0.81,p&amp;lt;0.001). A bipolar voltage value &amp;lt;1.5mV in the sub-tricuspid region yielded a sensitivity of 98% and a specificity of 53% for ARVC diagnosis (Figure 1a-b, showing the typical RV free wall "C-scar" in ARVC and normal values for the RV apex in less advanced disease stages). A positive correlation between bipolar voltage values and an orthogonal catheter orientation (46°-90°: r=0.106,p&amp;lt;0.001) as well as a higher catheter contact force (r=0.054,p=0.008), and a negative correlation between bipolar voltage values and QRS duration (r=-0.370,p&amp;lt;0.001) was found. Conclusions For the first time a systematic analysis of RV endocardial low voltage areas in ARVC patients as compared to controls by using CFSC was performed, and confirmed that RV voltages are generally lower in ARVC as compared to controls, with the sub-tricuspid area showing the lowest values and highest discriminatory power vs controls.

PO-05-232 SAFETY AND EFFICACY OF ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA ABLATION USING AN IRRIGATED CONTACT FORCE CATHETER

Atrioventricular Nodal Reentry Tachycardia (AVNRT) ablation is a common procedure in contemporary electrophysiology practice. Traditionally ablation for AVNRT has been performed with non-irrigated catheters, guided by fluoroscopy and intracardiac electrograms. Increasingly electroanatomic mapping systems are utilized to allow for low or zero fluoroscopy procedures. Contact force catheters can provide information on tissue contact and stability that can be helpful in patients with challenging anatomy. Available contact force catheters are irrigated and concern has existed for using irrigated tip ablation catheters for AVNRT ablation due to the potential to create lesions that are too deep and could increase the risk for AV block. To describe the safety and efficacy for the use of irrigated contact force catheters for ablation of AVNRT Review of procedural data from patients undergoing radiofrequency ablation for AVNRT using electroanatomical mapping combined with irrigated contact force catheter. Fifty patients from 4 regions across Australia were included. Procedures were performed by 9 experienced electrophysiologists. No periprocedural complications occurred. Procedural success was achieved in 96%. Median lesion contact force (25-75 centile) was 4.0(2-6)g. Peak power was set at 50W, median baseline irrigation was at 2ml/min and 6ml/min during ablation. Median number of lesions was 9(4.5-17.5); with total ablation time of 203(95-366) seconds. 60% of the cases were performed without fluoroscopy. Ablation of AVNRT using an irrigated contact force catheter on low irrigation setting is safe and effective. Contact force catheters using low irrigation settings may safely improve success rates in AVNRT with challenging anatomy or ablation of other substrate in close proximity to vital structures.

AB-452672-4 POINT-BY-POINT PULSED FIELD ABLATION USING A MULTIMODALITY GENERATOR: COMPARISON WITH RADIOFREQUENCY ABLATION IN REMAPPED CHRONIC SWINE HEARTS.

In recent years, Pulsed Field Ablation (PFA) has emerged as a novel non thermal energy source for ablation. To compare lesion durability and collateral damage between unipolar/biphasic PFA and RF delivered through a contact-force sensing catheter both in a point-by-point fashion. A 4 arm pre-clinical study (n=12 swine) was designed with the multimodality generator TRUPULSE™ 2. PFA was delivered with nominal dose (12 pulses) in Group 1 whereas a high PFA dose (24 pulses) was used to evaluate energy safety in Group 2. RF arms served as controls with energy deployed through multimodality (Group 3) or market available (Group 4) generators. A contact-force catheter was used to focally deliver PFA/RF at the right superior pulmonary vein (RSPV), left atrial posterior wall (LAPW) and Roof, mitral isthmus (MI), cavotricuspid Isthmus (CTI), and RA posterior wall (RAPW). Average contact force was 12.7±3.7g. Animals were remapped at immediate post and 28 days post ablation. All animals were euthanized at 28 days and gross necropsy and histology followed. Acute RSPV isolation was achieved in all animals (Figure 1). At 28 days, remapping showed that RSPV isolation was maintained in all but one animal (Group 1) showing an electrical gap confirmed on histology. RAPW, CTI, MI (with exception of 2 animals, 1 in Group 2 and 1 in Group 3), and LAPW were maintained per histology as well. Differently from RF, both PFA arms had essentially similar histopathologic effect showing benign mature scar tissue repair with no necrosis nor inflammation (Figure 1). PFA applied to the RA lateral and posterior wall did elicit phrenic nerve response during ablation confirming ablations were done on the nerve. However, at 28 days remap, the nerve was stimulated and, in all animals, remained intact with no signs of damage on necropsy or histology. Representative samples were selected from the downstream/upstream organs including the brain, rete mirabile, heart, lungs, liver, esophagus, spleen, and kidneys, which showed no evidence of thrombo-embolic events. In swine models, point-by-point unipolar/biphasic PFA ablation showed durable PVI lesions acutely and at remapping without any sign of collateral damage after 28 days remap study. On histology, PFA lesions evolved with scar tissue without signs of necrosis nor inflammation. Further studies are needed to investigate the long-term safety and efficacy of this point-by-point PFA contact force sensing catheter.

AB-452663-2 LEFT ATRIAL BOX ISOLATION GUIDED BY FORCE-POWER-TIME FORMULA (ABLATION INDEX): HIGH PREVALENCE OF EPICARDIAL CONDUCTION VIA SEPTOPULMONARY BUNDLE IN ATRIAL FIBRILLATION PATIENTS

Circumferential, continuous, transmural atrial lesions are desired to facilitate pulmonary vein (PV) isolation. However, atrial wall thickness around the PV is variable (5-6 mm in the superior/anterior segments and 2-4 mm in the inferior/posterior segments). Previous experimental studies have shown that radiofrequency (RF) lesion depth and diameter can be predicted by a logarithmic formula using contact force (CF), RF power and application time (Force-Power-Time Formula, Ablation Index, AI). The purpose of this study was to test the ability of AI guided ablation to achieve left atrial (LA) box isolation by a single RF encirclement and examine the location of residual conduction (gap) within the box in patients with atrial fibrillation (AF). In 42 patients with AF, LA box isolation was performed using a 7.5Fr CF catheter (ThermoCool SmartTouch SF, Biosense Webster) and CARTO system. Using RF power (35-40Watts) and CF (5-45g), a target AI value of 380-400 was used for posterior/inferior segments with an inter-lesion distance (ILD) of 4mm and a target AI value of 550-600 for anterior/superior/septal segments with an ILD of 6mm along the box circumference (Figure). RF was delivered until AI reached target values or terminated prematurely when esophageal temperature reached <38.5°C. After the first encirclement along the box line, activation mapping was performed to confirm box isolation and identify gap locations. Total RF time for box isolation was 27.2±4.6 min and box circumference length was 21.2±2.5 cm. Complete box isolation was obtained by the first encirclement in 17/42 (40%) pts. In the remaining 25/42 (60%) pts, activation mapping within the box lesion set identified earliest atrial activation along the ablation line in only 4/42 (10%) pts (indicating endocardial gaps), whereas activation mapping within the box identified earliest atrial activation at a site distant from the ablation line in 21/42 (50%) pts, suggesting epicardial conduction through a septopulmonary bundle (Figure). Focal ablation at endocardial gaps along the ablation line or at the epicardial focal breakouts within the box resulted in compete box isolation in all 25 pts. LA box isolation guided by AI effectively prevented endocardial gaps along the ablation line. However, epicardial conduction via a septopulmonary bundle was often observed (50%).

Porous tip radiofrequency ablation catheter reduced heart failure-related complications and healthcare resource utilization in paroxysmal atrial fibrillation patients.

A 56-hole porous tip radiofrequency catheter was developed to provide more uniform cooling with less fluid delivery than a prior 6-hole irrigated design. This study aimed to evaluate the impact of contact force (CF) ablation with the porous tip on complications (congestive heart failure [CHF] and non-CHF related), healthcare resource utilization, and procedural efficiency in patients undergoing de novo paroxysmal atrial fibrillation (PAF) ablations in a real-world setting. Consecutive de novo PAF ablations were performed between February 2014 and March 2019 by six operators at a single US academic center. The 6-hole design was used through December 2016 with the 56-hole porous tip adopted in October 2016. The outcomes of interest included symptomatic CHF presentation and CHF-related complications. Of 174 patients who were included, mean age was 61.1± 10.8 years, 67.8% were male, and 25.3% had a history of CHF. Ablation with the porous tip catheter significantly decreased fluid delivery (1177 vs. 1912 mL with the 6-hole design; p< .0001). CHF-related complications within 7 days, particularly fluid overload, were substantially reduced with the porous tip (15.2% vs. 5.3% of patients; p =.0281) and the proportion of patients with symptomatic CHF presentation within 30 days postablation was significantly lower (14.7% vs. 32.5%; p =.0058). The 56-hole porous tip led to significantly reduced CHF-related complications and healthcare utilization in PAF patients undergoing CF catheter ablation when compared to the prior 6-hole design. This reduction likely results from the significant decrease in fluid delivery during the procedure.

Very long term outcomes of atrial fibrillation ablation

Little is known about the very long term durability of atrial fibrillation (AF) ablation. The purpose of this study was to evaluate very long term AF ablation outcomes. We followed 5200 patients undergoing 7145 ablation procedures. We evaluated outcomes after single and multiple ablation procedures for paroxysmal (PAF; 33.6%), persistent (PeAF; 56.4%), and long-standing (LsAF; 9.9%) AF. We compared 3 ablation eras by initial ablation catheter: early (101 patients) using solid big tip (SBT) catheters (October 2003 to December 2005), intermediate (2143 patients) using open irrigated tip (OIT) catheters (December 2005 to August 2016), and contemporary (2956 patients) using contact force (CF) catheters (March 2014 to December 2021). AF freedom at 5, 10, and 15 years was as follows: initial ablation: PAF 67.8%, 56.3%, 47.6%; PeAF 46.6%, 35.6%, 26.5%; and LsAF 30.4%, 18.0%, 3.4%; final ablation: PAF 80.3%, 72.6%, 62.5%; PeAF 60.1%, 50.2%, 42.5%; and LsAF 43.4%, 32.0%, 20.6%. For PAF and PeAF, CF ablation procedures were better than OIT ablation procedures (P < .0001) and both were better than SBT ablation procedures (P < .001). LsAF had no outcome improvement over the eras. The 8-year success rate after final ablation for CF, OIT, and SBT catheter eras was as follows: PAF 79.1%, 71.8%, 60.0%; PeAF 55.9%, 50.7%, 38.0%; and LsAF 42.7%, 36.2%, 31.8%. Highest AF recurrence was in the first 2 years, with a 2- to 15-year recurrence of 2%/yr. Success predictors after initial and final ablation procedures were younger age, smaller left atrium, shorter AF duration, male sex, less persistent AF, lower CHA2DS2-VASc score, fewer drugs failed, and more recent catheter era. After year 2, there is 2%/yr recurrence rate for all AF types. Ablation success is best in the CF catheter era, intermediate in the OIT era, and worst in the SBT era. Over the ablation eras, outcomes improved for PAF and PeAF but not for LsAF. We should follow patients indefinitely after ablation. We need an understanding of how to better ablate more persistent AF.

The impact of the procedural parameters on the lesion characteristics associated with AF recurrence: Late-gadolinium enhancement magnetic resonance imaging (LGE-MRI) analysis.

Lesion gaps assessed by late-gadolinium enhancement magnetic resonance imaging (LGE-MRI) are associated with the atrial fibrillation (AF) recurrence after pulmonary vein isolation. Animal studies have demonstrated that the catheter-contact force (CF), stability, and orientation are strongly associated with lesion formation. However, the impact of those procedural factors on the lesion characteristics associated with AF recurrence has not been well discussed. A total of 30 patients with paroxysmal AF who underwent catheter ablation were retrospectively enrolled. Radiofrequency (RF) applications were performed with 35 W for 30 s in a point-by-point fashion under esophageal temperature monitoring. The inter-lesion distance was 4 mm. The lesions were visualized by LGE-MRI 3 months postprocedure and assessed by the LGE volume (ml), gap number (GN), and average gap length (AGL [mm]). The gaps were defined as nonenhancement sites of >4 mm. The procedural factors including the catheter-CF, stability, and orientation were calculated on the NavX system. Six (20%) of 30 patients had AF recurrences 12 months postablation. A univariate analysis demonstrated that the AGL was associated with AF recurrence (hazard ratio [HR]: 1.20, confidence interval [CI]: 1.03-1.42, p = .02). All AF recurrence were found in patients with an AGL of >7 mm. The catheter-CF and stability were associated with an AGL of >7 mm, but not the orientation (CF-HR: 0.62, CI: 0.39-0.97, p = .038; stability-HR: 0.8, CI: 0.66-0.98, p = .027). RF ablation with a low CF and poor catheter stability has a potential risk of creating large lesion gaps associated with AF recurrence.

756 ZERO OR NEAR ZERO FLUOROSCOPY CATHETER ABLATION OF PREMATURE VENTRICULAR CONTRACTIONS: A MULTICENTRE EXPERIENCE

Abstract Background Catheter ablation has become an established treatment option for premature ventricular complexes (PVCs). It is well known that the use of fluoroscopy exposes patients and medical staff to potentially harmful stochastic and deterministic effects of ionising radiations. We sought to analyse procedural outcomes in terms of safety and efficacy using a “zero” or “near zero” X rays approach for treatment of PVCs. Methods The present retrospective, multicentre, observational study included 131 patients having undergone catheter ablation of PVCs using zero or “near zero” (less than 2 minutes) fluoroscopy between 2016 and 2020 in 4 high-volume centres. Baseline characteristics of the population, acute success and complications derived from the procedure were evaluated, as well as recurrence rate during follow-up. Results Median age was 51.0 years old [38-63], males were 77 (58.8%). Most often cause of ablation were palpitations (90.0%), followed by reduced left ventricular ejection fraction (4.6%) and pre-syncope (14.5%). Among the study population, 26 (19.8%) had a cardiopathy. The median PVC burden before ablation was 15.1% [6%-22.4%]. The most frequent PVC origin was right ventricular outflow tract (n=72; 55.0%) followed by the left ventricle (n=21; 16.0%), LVOT and cusps (n=18; 13.7%),aortomitral continuity (n=7; 5.3%). A 3D electro-anatomical mapping system was used in all cases as well as a contact force catheter for mapping and ablation. The mean maximum radiofrequency power applied was 32.9 ± 4.1 W (median time: 370 sec). Median number of applications was 4.5 and mean total procedural time was 117.3 ± 47.5 minutes. Median best prematurity was 31.5 msec. We used isoprenaline in order to induce PVCs in 42% of cases and suppression of PVC was achieved in 127 patients (96.9%). There was only 2 complication (femoral hematoma and arteriovenous fistula conservatively treated). At 12 months, a complete success was documented in 109 patients (83.2%), a reduction in PVC burden was achieved in other 18 patients (13.7%) and a failure was recorded in 4 patients (3.1%). Conclusion The PVC ablation with “zero” or “near-zero” fluoroscopy is a safe procedure with no major complications and good rates of success and recurrence in our multicentre experience.

Use of contact force technology for cardiac arrhythmia ablation in children.

New techniques for cardiac arrhythmia ablation, such as contact force (CF) technology, have emerged recently. These catheters provide information about adequate tissue contact for optimal lesions. In adults, these techniques have shown greater accuracy, reduced arrhythmia recurrence and complications, and higher success rates. However, data on pediatric patients are limited. The purpose of this study was to describe the experience with arrhythmia ablation using CF catheters in the pediatric population. A retrospective cross-sectional descriptive study of all patients <18 years old undergoing cardiac 3-dimensional mapping and ablation with CF between March 2016 and June 2022 was performed. A total of 321 patients were included (51.40% male; mean age 12.26 years). The most frequent arrhythmia were supraventricular tachycardia (SVT) mediated by accessory pathways (APs) (atrioventricular reentrant tachycardia in 82.24%, ventricular arrhythmia in 11.21%, atrial tachycardia in 5.92%). Mean procedural time was 2.86 ± 1.2 hours, and average contact used was 14.33g ± 6.88g. The success rate of ablation was 97.82% with a low risk of complications. This is the largest published series of CF technology use in patients <18 years old. In the pediatric population, CF ablation is a safe procedure with high success rates and can be used for most arrhythmic substrates. The most frequent tachycardia observed in this study was SVT mediated by APs. Contact with 14g is safe and yields an excellent outcome in children. The presence of structural heart anomalies and previous ablation procedures decreased the success rate.

Economic Evaluation of Contact Force Catheter Ablation for Persistent Atrial Fibrillation in the United States.

Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, and it increases the risk of stroke, heart failure, and other cardiac complications. Catheter ablation is well-established as a treatment for paroxysmal AF, and the recent PRECEPT (Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH SF Catheter Evaluated for Treating Symptomatic Persistent AF) clinical trial resulted in the catheter gaining approval for the treatment of persistent AF in the United States. To construct an economic simulation model, based on the results of the PRECEPT trial, to monetize the impact of radiofrequency catheter ablation (RFCA) compared with medical therapy (MT). Cost-offset and break-even analyses were performed to assess the economic impact of RFCA vs MT for adult persistent AF patients. Three perspectives were considered: commercial payers, Medicare, and self-insured employers. A cohort-level decision tree model was developed and validated in TreeAge Pro 2019. Sensitivity analyses were performed to determine the robustness of findings. For all 3 types of payer, RFCA had a higher initial cost compared with MT. However, reductions in health care utilization after ablation, driven by decreased cardiovascular hospitalizations, led to an annual cost offset of between $5037 and $8402 after the first year. Projecting this forward resulted in an estimated cost break-even after 5.9, 4.2, and 5.1 years for commercial payers, Medicare, and self-insured employers, respectively. In addition to providing clinical benefits, RFCA may be a valuable economic investment for U.S. payers, substantially reducing utilization after the first year.